Description
FR122047 is a selective inhibitor of COX-
1. The IC
50 values for inhibition of human COX-
1 and COX-
2 are 0.028 and 65 μM, respectively. In human platelet-
rich plasma, FR122047 inhibits arachidonic acid, collagen, and ADP-
induced platelet aggregation with an IC
50 of 180-
200 nM, which is nearly 100 times more potent than aspirin. Unlike aspirin, FR122047 does not induce gastric damage upon oral administration at doses (100 mg/kg) far in excess of the dose needed for complete suppression of platelet COX-
1. In some models of inflammation, such as collagen-
induced arthritis in the rat, FR122047 has an anti-
inflammatory effect, implying a role for COX-
1 in these models.
Biological Activity
Selective cyclooxygenase-1 (COX-1) inhibitor (IC 50 values are 0.028 and 65 μ M for COX-1 and COX-2 respectively). Antiplatelet, analgesic and anti-inflammatory following oral administration in vivo .